Royal Canin Unveils Expansion to Gastrointestinal Portfolio, Announces Five New Diets

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

ST. CHARLES, Mo., April 16, 2024 /PRNewswire/ -- ROYAL CANIN® U.S., a division of Mars, Incorporated and leader in pet health nutrition, has announced an expansion to its Veterinary Gastrointestinal (GI) portfolio. Gastrointestinal issues are the 3rd and 4th most common issue in cats and dogs that prompt a veterinary visit, and tailored nutrition can have a significant impact in nourishing and supporting their GI tract and microbiome.1,2